OptraSCAN

OptraSCAN, founded in 2015, is a global leader in digital pathology, specializing in advanced technology aimed at revolutionizing diagnostics and patient care. The company offers cutting-edge digital pathology solutions, including brightfield slide scanners, histology slide scanners, and fluorescence slide scanners, to enhance the accuracy and efficiency of diagnostic processes. OptraSCAN leads the way in digital histopathology through the integration of advanced artificial intelligence (AI), offering solutions such as AI-powered pathology scanners and digital pathology artificial intelligence technologies designed to boost diagnostic accuracy and efficiency. The company is committed to making digital pathology accessible to all, providing compact and advanced scanning systems, and offers comprehensive solutions including cloud-based LIMS (CLOUDPath), image analysis tools (OptraASSAYS), and up to 10 TB of complimentary cloud storage. As a result, healthcare institutions are able to seamlessly transition from traditional microscopy to sophisticated digital pathology systems. OptraSCAN's goal is to ensure that healthcare systems worldwide can seamlessly adopt and benefit from their transformative digital pathology technologies. With their focus on improved precision, efficiency, and patient care, OptraSCAN is a leading company shaping the future of diagnostics in the Health Care and Medical Devices industries. Although there is no available information regarding its headquarter and last investment, the company's dedication to advancing digital pathology through AI technology demonstrates strong potential for growth and impact in the industry.